Bullous Pemphigoid (BP) Completed Phase 1 / 2 Trials for Rituximab (DB00073)

Also known as: Pemphigoid, Bullous / Bullous Pemphigoid / Pemphigoid / Bullous pemphigoid NOS

IndicationStatusPhase
DBCOND0074370 (Bullous Pemphigoid (BP))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00286325Rituximab in the Treatment of Patients With Bullous PemphigoidTreatment